Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-12
2011-10-25
Morris, Patricia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S345000, C546S300000, C546S301000
Reexamination Certificate
active
08044074
ABSTRACT:
The invention relates to compounds of formula Iin which R1, R2, R3, R4, R5, R6 and X have the meanings stated in the claims. The compounds are particularly suitable as antiarrhythmic active ingredients, in particular for the treatment and prophylaxis of atrial arrhythmias, for example atrial fibrillation (AF) or atrial flutter.
REFERENCES:
patent: 7495014 (2009-02-01), Charifson et al.
patent: 7569591 (2009-08-01), Charifson et al.
patent: 2004/0235886 (2004-11-01), Charifson et al.
patent: 2005/0038247 (2005-02-01), Charifson et al.
patent: 2005/0054673 (2005-03-01), Wirth
patent: 2007/0027177 (2007-02-01), Trotter et al.
patent: WO 2005-046578 (2005-05-01), None
Brendel Joachim
Englert Heinrich Christian
Pilorge Fabienne
Ruxer Jean-Marie
Wagner Michael
Bender Kelly L.
Morris Patricia
Ort Ronald G.
Sanofi-Aventis
LandOfFree
Substituted heterocycles, their use as medicament, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocycles, their use as medicament, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocycles, their use as medicament, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4288875